Several times a year, Sweet’s changes its recipe to capture the allergy-fighting power of season-specific, raw, local honey.
Honey contains traces of pollen – a common allergen. One common treatment for allergies is repeated exposure to small amounts of the trigger allergen. In 2013, researchers found that ingesting honey caused significant improvement in allergic rhinitis sufferers, and the benefit persisted for a month after honey consumption stopped.
Sweet’s Syrup is proud to partner with Herb’s Honey, based in Charlotte, NC. They maintain hundreds of beehives across nine North Carolina counties, harvesting in early spring, late spring, summer, and fall.
Depending on the time of year, your bottle of Sweet’s may contain a straight seasonal honey or a blend. Blends are designed to cover current allergens and help build resistance to upcoming allergy triggers. Fall honey has been incorporated into the newest batch of our syrup.
The honey in Sweet's Syrup is effective against allergens common east of the Mississippi River and south of the Mason-Dixon Line. North Carolina State University tested Herb’s Honey and found pollen from ragweed, sumac, sedum, crape myrtle, buckwheat, camellia sasanqua, goldenrod, sunflowers, wildflowers, zinnia, bee balm, lantana, and much more.
To reap the benefits of season-specific, raw, local honey along with the immune-boosting power of elderberry, cinnamon, clove, and ginger, we recommend drinking Sweet’s Syrup daily, beginning a month prior to your trigger season. An adult serving is 1 tablespoon per day, while children over age 1 can have 1 teaspoon. If you do experience seasonal allergy symptoms, using elderberry syrup with honey every three hours can help.
If you’re outside the Southeastern U.S., consider eating a spoonful of raw honey from your region each day for one month before and throughout your allergy season, in addition to drinking your daily Sweet’s.
-Tracy Dygert for Sweet’s Syrup
Source: Asha’ari, Zamzil, et al, 2013. Ingestion of honey improves the symptoms of allergic rhinitis: Evidence from a randomized placebo-controlled trial in the East Coast of Peninsular Malaysia. Annals of Saudi Medicine, 33 (5) pp. 469-475. ISSN 0256-4947.